Albenatide
(2R)-2-amino-3-[1-[3-[2-[2-[2-[4-[[(5S)-5,6-diamino-6-oxohexyl]amino]butylamino]-2-oxoethoxy]ethoxy]ethylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
Molecular Identity
Albenatide
(2R)-2-amino-3-[1-[3-[2-[2-[2-[4-[[(5S)-5,6-diamino-6-oxohexyl]amino]butylamino]-2-oxoethoxy]ethoxy]ethylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
PubChem CID: 86278325
2D Structure
Properties
C26H47N7O9S
Molecular Formula
633.80
Molecular Weight
g/mol
633.3156
Exact Mass
Da
-6
XLogP
Drug-like (Lipinski: < 5)
284
TPSA
May have limited oral absorption
7
H-Bond Donors
13
H-Bond Acceptors
912
Complexity
SMILES
Canonical SMILES
SMILES: C1C(C(=O)N(C1=O)CCC(=O)NCCOCCOCC(=O)NCCCCNCCCCC(C(=O)N)N)SCC(C(=O)O)NIsomeric SMILES
SMILES: C1C(C(=O)N(C1=O)CCC(=O)NCCOCCOCC(=O)NCCCCNCCCC[C@@H](C(=O)N)N)SC[C@@H](C(=O)O)NSynonyms(17)
Albenatide5Y7IGH3V3Q1031700-39-6albenatidaalbenatidumRefChem:1076318S3.34-(1-((23S)-23-((Exendin-4 heloderma suspectum precursor-(48-86)-peptidyl (exenatidyl))amino)-3,12,24-trioxo-7,10-dioxa-4,13,18,25-tetraazapentacosyl)-2,5-dioxopyrrolidin-3-yl)human serum albuminAlbenatide [INN]UNII-5Y7IGH3V3QCJC 1134PCCJC-1134-PCCJC 1134COE40KKG35orb1983726SCHEMBL29357894
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Albenatide
Loading drug network...